Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

Colossal Biosciences opens global HQ with 100 scientists focused on "de-extinction," using CRISPR to revive species like the ...

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

CRISPR Therapeutics (CRSP) has been making waves lately, especially after announcing promising early clinical data for its CTX310 program, a gene-editing therapy aimed at tackling cardiovascular ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG stands among them. CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneering ...

CRISPRgenee is a new method that combines gene silencing and cutting to improve loss-of-function studies in human cells.